Clinically Meaningful Improvements in Skin Quality After Treatment With DaxibotulinumtoxinA-lanm for Injection: The RADIANCE Study
Aesthetic Surgery Journal · 13.11.2026
DOI: 10.1093/asj/sjag255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aesthetic Surgery Journal, online erschienen am 13.11.2026. Verfasst von Brian S Biesman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dr Biesman is an oculofacial plastic surgeon, Department of Ophthalmology, Dermatology, and Otolaryngology, Vanderbilt University Medical Center, Nas…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Clinical observations suggest that injections of daxibotulinumtoxinA-lanm for injection (DAXI) in the glabella and forehead produce visible improvements in skin quality.
Objectives
To assess the effect of intramuscular DAXI on perceived skin quality and objectively quantify changes in skin texture.
Methods
In this phase 2a, open-label, single-arm study conducted at 2 US sites, 27 adult subjects with moderate to severe glabellar and forehead lines received 40 U and 24 U of DAXI in the glabella and frontalis, respectively. Efficacy endpoints were proportion of subjects achieving none or mild in glabellar or forehead line severity at maximum contraction at Day 28, investigator and subject assessments of skin quality, and changes in skin micro and macro texture assessed via 3D image analysis.
Results
At Day 28, DAXI treatment reduced investigator-rated wrinkle severity to none or mild in the glabella (100% of subjects) and forehead (89%). Most subjects and investigators agreed skin looked smooth and radiant, and 96% of subjects agreed results looked natural. 3D analysis revealed a significant improvement in skin texture at all follow-up visits. Mean change from baseline in micro texture was -2.8 µm and -4.3 µm in macro texture (p<0.001 for both), which exceeded the exploratory thresholds for clinically meaningful changes for 77% and 73% of patients, respectively.
Conclusions
Intramuscular injection of DAXI improved ratings of skin smoothness and radiance, corroborated by 3D image analysis demonstrating significant changes in surface topography. These results align with observations from clinical practice of visibly enhanced skin after treatment with DAXI.
Autor:innen und Institutionen
- Dr Biesman is an oculofacial plastic surgeon, Department of Ophthalmology, Dermatology, and Otolaryngology, Vanderbilt University Medical Center, Nashville, TN.
- Drs Sparrow, Brown, and Hollander are former employees of Revance, Nashville, TN.
- Dr Curcio is an adjunct assistant professor of health policy, Vanderbilt University School of Medicine, Nashville, TN.
- Dr Stephenson is a scientific advisor, injectables.
- Dr Gross is the vice president of clinical development and data science.
- Dr Gallagher is the chief scientific officer, Revance, Nashville, TN.
Zitieren
APA
Biesman, B. S., Sparrow, J., Curcio, N., Stephenson, J., Brown, J., Gross, T. M., Hollander, D. A., & Gallagher, C. J. (2026). Clinically Meaningful Improvements in Skin Quality After Treatment With DaxibotulinumtoxinA-lanm for Injection: The RADIANCE Study. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjag255
Vancouver
Biesman BS, Sparrow J, Curcio N, Stephenson J, Brown J, Gross TM, et al. Clinically Meaningful Improvements in Skin Quality After Treatment With DaxibotulinumtoxinA-lanm for Injection: The RADIANCE Study. Aesthetic Surgery Journal. 2026. doi:10.1093/asj/sjag255
BibTeX
@article{Biesman2026,
author = {Biesman, Brian S and Sparrow, Julia and Curcio, Natalie and Stephenson, Jason and Brown, Jessica and Gross, Todd M and Hollander, David A and Gallagher, Conor J},
title = {Clinically Meaningful Improvements in Skin Quality After Treatment With DaxibotulinumtoxinA-lanm for Injection: The RADIANCE Study},
journal = {Aesthetic Surgery Journal},
year = {2026},
doi = {10.1093/asj/sjag255}
}
EUVIMED